![Mark Velleca](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 158 139 $ in data 31/05/2026
Mark A. Velleca was the founder of Gilead Connecticut, Inc., founded in 1999, where the title held was Senior Vice President from 1999 to 2010.
Current jobs include Chairman, President & Chief Executive Officer at Black Diamond Therapeutics, Inc. since 2023; Chairman at iOnctura SA since 2024; Chairman at Turbine Hálózatelemzo Kutatási Fejlesztési Kft.
since 2021; Director at CREATE Medicines, Inc. (Massachusetts) since 2023; Director at IMMvention Therapeutix, Inc.; and Clinical Assistant Professor at Yale University.
Former jobs include President, Chief Executive Officer & Director at StrideBio, Inc. from 2021 to 2023; Chairman at Turbine Simulated Cell Technologies Ltd.; Director at BioMarker Strategies LLC from 2010 to 2012; Director at Intellikine LLC from 2007 to 2012; Director at G1 Therapeutics, Inc. from 2021 to 2023; Principal at Yale-New Haven Hospital, Inc.; Executive VP, Chief Policy & Advocacy Officer at Blood Cancer United, Inc. from 2012 to 2014; and Venture Partner at Hatteras Venture Partners from 2021 to 2023.
Education includes a doctorate from the University of Washington and an undergraduate degree from Yale University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/04/2026 | 71.234 ( 0,12% ) | 158 139 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Amministratore Delegato | 16/09/2023 |
Turbine Hálózatelemzo Kutatási Fejlesztési Kft.
 Turbine Hálózatelemzo Kutatási Fejlesztési Kft. Packaged SoftwareTechnology Services Develops AI software which helps to find drugs for cancer | Presidente | 28/04/2021 |
iOnctura SA
 iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Presidente | 01/01/2024 |
Myeloid Therapeutics, Inc.
 Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Direttore/Membro del Consiglio | - |
IMMvention Therapeutix, Inc.
 IMMvention Therapeutix, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies | Direttore/Membro del Consiglio | - |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| G1 THERAPEUTICS, INC. | Amministratore Delegato | 01/01/2021 |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Corporate Officer/Principal | 01/02/2023 |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Amministratore Delegato | 01/01/2023 |
| ░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
BioMarker Strategies LLC
 BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology Develops medicines for cancer | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and biotechnology chemicals | Health Technology |
Yale-New Haven Hospital, Inc.
 Yale-New Haven Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services and medical courses | Health Services |
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization dedicated to funding research, education and support services for all blood cancers | Commercial Services |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Finance |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
Turbine Hálózatelemzo Kutatási Fejlesztési Kft.
Turbine Hálózatelemzo Kutatási Fejlesztési Kft. Packaged SoftwareTechnology Services Develops AI software which helps to find drugs for cancer | Technology Services |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
IMMvention Therapeutix, Inc.
IMMvention Therapeutix, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies | Health Technology |
Turbine Simulated Cell Technologies Ltd.
 Turbine Simulated Cell Technologies Ltd. Packaged SoftwareTechnology Services Provides AI solutions to understand oncology patients with simulated cells | Technology Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
